IED Vaccine in Adults – VAC52416BAC3001

Phase 3 Study to Assess the Efficacy, Safety And Immunogenicity of Vaccination With ExPEC9V in the Prevention of Invasive Extraintestinal Pathogenic Escherichia coli Disease in Adults Aged 60 Years And Older with a History of Urinary Tract Infection in the Past 2 Years

Register Today!

Trial Information

Start DateOctober 2022
End Date~October 2025
Trial Duration3 years
Number of Visits2 + 6 phone calls
Lead CRCAndrea Carruthers
StatusIn Start-Up

For additional information
on this trial contact: